Effect of Thrower's Ten Exercises on Flick Movement Kinematics in Underwater Hockey

September 21, 2023 updated by: Leyla Eraslan, Hacettepe University

Underwater hockey is a team game which is played at the bottom of the swimming pool with palettes, a mask, a snorkel, earmuffs, a stick, and a puck. The aim of the game is for one of the teams to try to score goals to the goalpost of the other by using a flicking movement. The players can drag the puck, being a kind of ball, or pass it to a teammate to reach the opponent's goalpost. The puck is passed by way of pushing or flicking.

The Thrower's Ten exercises are used for such sports branches, which involve the upper extremity and particularly the overhead activity and throwing, in order to ensure coordination, proprioception, balance and symmetry in the double upper extremity. The Thrower's Ten exercises are comprised of special exercises selected for the improvement of the flexibility, strength and endurance of the major muscles that are frequently used for throwing and overhead activity such as deltoid muscles, supraspinatus muscles, latissimus dorsi, biceps, triceps and wrist extensors. The Thrower's Ten exercises are an exercise program that focuses on the scapular muscles, particularly on posterior rotator cuff muscles in order to ensure the balance of the anterior and the posterior shoulder muscles.

The aim of this study is to evaluate the effects of The Thrower's Ten exercise program on the flicking movements in underwater hockey players.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Underwater hockey is a team game which is played at the bottom of the swimming pool with palettes, a mask, a snorkel, earmuffs, a stick, and a puck. The aim of the game is for one of the teams to try to score goals to the goalpost of the other by using a flicking movement. The players can drag the puck, being a kind of ball, or pass it to a teammate to reach the opponent's goalpost. The puck is passed by way of pushing or flicking.

The Thrower's Ten exercises are used for such sports branches, which involve the upper extremity and particularly the overhead activity and throwing, in order to ensure coordination, proprioception, balance and symmetry in the double upper extremity. The Thrower's Ten exercises are comprised of special exercises selected for the improvement of the flexibility, strength and endurance of the major muscles that are frequently used for throwing and overhead activity such as deltoid muscles, supraspinatus muscles, latissimus dorsi, biceps, triceps and wrist extensors. The Thrower's Ten exercises are an exercise program that focuses on the scapular muscles, particularly on posterior rotator cuff muscles in order to ensure the balance of the anterior and the posterior shoulder muscles.

The aim of this study is to evaluate the effects of The Thrower's Ten exercise program on the flicking movements in underwater hockey players.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
17

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Ankara, Turkey, 06100
        • Hacettepe University, Faculty of Health Sciences, Dept. of Physiotherapy and Rehabilitation

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • 1st league healthy underwater hockey players

Exclusion Criteria:

  • Previous shoulder injury

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Thrower's Ten Exercise Group
the athletes were subjected to "Thrower's Ten" exercise program under the supervision of the same physiotherapist 3 days a week for a period of 6 weeks in addition to the routine practice programs thereof. Each session started with a 10-minute warm-up program and ended with a 10-minute cool-down program. The warm-up program included low-intensity aerobic activities and short stretching exercises. Stretching exercises for anterior-posterior-inferior capsule, right and left trapezoid muscles, chintug as well as posterior-lateral neck and latissimus dorsi muscles were given. Following the exercises, the athletes were made to perform low-intensity jogging and static stretching exercises. All athletes, who were included in the study sample, continued attending their 2-hour routine pool practice on 4 days a week in addition to the "Thrower's Ten" exercises for 6 weeks.
Other: Thrower's Ten Exercise Group
the athletes were subjected to "Thrower's Ten" exercise program under the supervision of the same physiotherapist 3 days a week for a period of 6 weeks in addition to their routine practice programs.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Flicking Distance Measurement
Time Frame: from baseline to six weeks after treatment sessions
Flicking Distance will be measured by using video cameras. Assessment will be recorded at baseline and the end of the six weeks treatment sessions
from baseline to six weeks after treatment sessions

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Hacettepe University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
June 1, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
July 15, 2023

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
August 30, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
May 29, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
June 7, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
June 8, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
September 25, 2023

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
September 21, 2023

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
September 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • GO 13/307

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

We will share IPD when we recruiting the patients

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings